BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $94,307,500 | +14.9% | 875,000 | +1.2% | 0.56% | +29.3% |
| Q1 2024 | $82,053,900 | +2.8% | 865,000 | 0.0% | 0.43% | -12.1% |
| Q4 2023 | $79,787,600 | +52.8% | 865,000 | -16.8% | 0.49% | +26.4% |
| Q3 2023 | $52,228,800 | +65.3% | 1,040,000 | +108.0% | 0.39% | +143.4% |
| Q2 2023 | $31,600,000 | +18.0% | 500,000 | +100.0% | 0.16% | +59.0% |
| Q4 2021 | $26,778,000 | +160.5% | 250,000 | +150.0% | 0.10% | +138.1% |
| Q3 2021 | $10,281,000 | – | 100,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |